Review article: non‐alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations
出版年份 2021 全文链接
标题
Review article: non‐alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-08-21
DOI
10.1111/apt.16575
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
- (2021) Suetonia C Palmer et al. BMJ-British Medical Journal
- Association of non-alcoholic fatty liver disease and all-cause mortality in hospitalized cardiovascular disease patients
- (2021) Surasak Saokaew et al. MEDICINE
- The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment
- (2021) Jingwen Zhou et al. MEDICINE
- Effect of Different Exercise Methods on Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression
- (2021) Yingzhe Xiong et al. International Journal of Environmental Research and Public Health
- Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease
- (2020) Jacqueline B. Henson et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Obeticholic acid for the treatment of nonalcoholic steatohepatitis: Expectations and concerns
- (2020) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
- (2020) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of SGLT2 Inhibitors on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Meta‐Analysis of Randomized Controlled Trials
- (2020) Baodi Xing et al. Journal of Diabetes Investigation
- Higher fatty liver index is associated with increased risk of new onset heart failure in healthy adults: a nationwide population-based study in Korea
- (2020) Jae-Hyung Roh et al. BMC Cardiovascular Disorders
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
- (2020) Qing Ye et al. Lancet Gastroenterology & Hepatology
- Association between non-alcoholic fatty liver and acute cerebral infarction: a protocol of systematic review and meta-analysis
- (2020) Ya-Juan Zhang et al. MEDICINE
- Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
- (2020) Juan Pablo Arab et al. Annals of Hepatology
- Commentary: nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name
- (2020) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease
- (2020) Evangelia Makri et al. ARCHIVES OF MEDICAL RESEARCH
- NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment
- (2020) Giovanni Targher et al. DIABETES & METABOLISM
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- 6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review
- (2020) Zobair M. Younossi et al. GASTROENTEROLOGY
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: an updated meta-analysis
- (2019) Alessandro Mantovani et al. LIVER INTERNATIONAL
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis
- (2019) Bin Liu et al. Hepatology International
- CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients
- (2019) Paul J. Pockros et al. LIVER INTERNATIONAL
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug’s effect on cardiovascular disease and non-alcoholic steatohepatitis
- (2018) Mayer B. Davidson et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease
- (2018) Yao-Yao Zhou et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease
- (2018) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?
- (2018) Stergios A. Polyzos et al. HEPATOLOGY
- The effect of antidiabetic medications on non-alcoholic fatty liver disease (NAFLD)
- (2018) Laura Iogna Prat et al. Hormones-International Journal of Endocrinology and Metabolism
- Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure
- (2018) Filippo Valbusa et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004–2012
- (2018) Thomas R McCarty et al. Surgery for Obesity and Related Diseases
- Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease: Review and meta-analyses
- (2018) Jaehee Ahn et al. CLINICAL NUTRITION
- Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: A systematic review and meta-analysis
- (2018) Karn Wijarnpreecha et al. DIGESTIVE AND LIVER DISEASE
- Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-Analysis
- (2018) Yung Lee et al. Clinical Gastroenterology and Hepatology
- Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
- (2018) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals
- (2017) Bo Kobberø Lauridsen et al. EUROPEAN HEART JOURNAL
- Increased arterial stiffness in nonalcoholic fatty liver disease
- (2017) Veeravich Jaruvongvanich et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups
- (2017) Shiv Chitturi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment
- (2017) Vincent Wai-Sun Wong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
- (2017) Ryuki Hashida et al. JOURNAL OF HEPATOLOGY
- Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists
- (2017) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis
- (2017) Christina N Katsagoni et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
- (2017) Vasilios G. Athyros et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis
- (2017) Stuart McPherson et al. PLoS One
- The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis
- (2017) Karn Wijarnpreecha et al. Clinics and Research in Hepatology and Gastroenterology
- Efficacy and safety of glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2017) Yajie Dong et al. Clinics and Research in Hepatology and Gastroenterology
- Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2017) Giovanni Musso et al. JAMA Internal Medicine
- Exercise-based Interventions for Nonalcoholic Fatty Liver Disease: A Meta-analysis and Meta-regression
- (2016) Lorenzo A. Orci et al. Clinical Gastroenterology and Hepatology
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) et al. DIABETOLOGIA
- Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysis
- (2016) Veeravich Jaruvongvanich et al. DIGESTIVE AND LIVER DISEASE
- Aortic valve sclerosis as a marker of atherosclerosis: Novel insights from hepatic steatosis
- (2016) Matteo Nicola Dario Di Minno et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure
- (2016) Filippo Valbusa et al. MEDICINE
- Nonalcoholic fatty future disease
- (2016) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Epidemiology and natural history of non-alcoholic fatty liver disease
- (2016) Yousef Fazel et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Adipokines in nonalcoholic fatty liver disease
- (2016) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review
- (2016) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of Bariatric Surgery on Mortality, Cardiovascular Events, and Cancer Outcomes in Obese Patients: Systematic Review and Meta-analysis
- (2016) Xu Zhou et al. OBESITY SURGERY
- Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial
- (2016) Shahinul Alam et al. Saudi Journal of Gastroenterology
- Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
- (2016) Heidi Storgaard et al. PLoS One
- Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis
- (2016) Shunquan Wu et al. Scientific Reports
- Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults
- (2015) Shivank A. Madan et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- The dual and opposite role of theTM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta-analysis
- (2015) Carlos J. Pirola et al. HEPATOLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Nonalcoholic fatty liver disease and statins
- (2015) Konstantinos Tziomalos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Long-Term Effects of Bariatric Surgery on Type II Diabetes, Hypertension and Hyperlipidemia: A Meta-Analysis and Meta-Regression Study with 5-Year Follow-Up
- (2014) Cristian Ricci et al. OBESITY SURGERY
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
- (2014) Giovanni Musso et al. PLOS MEDICINE
- Extrahepatic complications of nonalcoholic fatty liver disease
- (2013) Matthew J. Armstrong et al. HEPATOLOGY
- Nonalcoholic Fatty Liver Disease
- (2012) Stergios A. Polyzos et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
- (2011) G. Vernon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Vitamin E and the Risk of Prostate Cancer
- (2011) Eric A. Klein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bariatric surgery: a systematic review and network meta-analysis of randomized trials
- (2011) R. Padwal et al. Obesity Reviews
- Rosiglitazone Revisited
- (2010) Steven E. Nissen et al. ARCHIVES OF INTERNAL MEDICINE
- Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
- (2010) Vasilios G Athyros et al. LANCET
- Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis
- (2010) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review
- (2008) Silvia Sookoian et al. JOURNAL OF HEPATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started